journal article·2023-05Open access

Genomic Landscape and Potential Regulation of RNA Editing in Drug Resistance

Xu Zhou, Ramkrishna Mitra, Fei Hou, Shunheng Zhou, Lihong Wang, Wei Jiang

Advanced Science· Volume 10· Issue 14

Abstract

Abstract Adenosine‐to‐inosine RNA editing critically affects the response of cancer therapies. However, comprehensive identification of drug resistance‐related RNA editing events and systematic understanding of how RNA editing mediates anticancer drug resistance remain unclear. Here, 7157 differential editing sites (DESs) are identified from 98 127 informative RNA editing sites in tumor tissues, many of which are validated in cancer cell lines. Diverse editing patterns of DESs are discovered in resistant samples, which could not be fully explained by adenosine deaminase acting on RNA enzymes. Some RNA‐binding proteins are identified that potentially regulate these editing events. Notably, the DESs are significantly enriched in 3’‐untranslated regions (3’‐UTRs). The impact of DESs in 3’‐UTR on the microRNA (miRNA) regulations is explored, and some triplets (DES, miRNA, and gene) that may contribute to drug resistance are identified. In addition, it is determined that the functions of genes enriched with DESs are associated with drug resistance, such as apoptosis, drug metabolism, and DNA synthesis involved in DNA repair. An online resource ( http://www.jianglab.cn/REDR/ ) to support convenient retrieval of DESs is also built. The findings reveal the landscape and potential regulatory mechanism of RNA editing in drug resistance, providing new therapeutic targets for reversing drug resistance.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: RNA regulation and disease · RNA modifications and cancer · RNA Research and Splicing

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biomedical Engineering Nanjing University of Aeronautics and Astronautics Nanjing 211106 P. R. China

Department of Pharmacology Physiology, and Cancer Biology Sidney Kimmel Cancer Center Thomas Jefferson University Philadelphia Pennsylvania 19107 USA

Department of Pathophysiology School of Medicine Southeast University Nanjing 210009 P. R. China

Funding

National Natural Science Foundation of China

References (76)

Show source-provided references
1. Furue H. · Cancer Chemother. · 2003 · 30 · 1404
2. 10.1016/S0140-6736(17)31662-810.1016/S0140-6736(17)31662-8 ↗
3. Wagner A. D. · Cochrane Database Syst. Rev. · 2017 · 8
4. 10.1038/s41586-019-1730-110.1038/s41586-019-1730-1 ↗
5. 10.1038/nrd198410.1038/nrd1984 ↗
6. Jeon S. M. · Exp. Mol. Med. · 2018 · 50 · 1
7. 10.1016/j.semcancer.2017.11.01810.1016/j.semcancer.2017.11.018 ↗
8. 10.1200/JCO.18.0205010.1200/JCO.18.02050 ↗
9. 10.1016/j.canlet.2016.01.04310.1016/j.canlet.2016.01.043 ↗
10. 10.1186/s12943-020-01185-710.1186/s12943-020-01185-7 ↗
11. 10.1038/nrc359910.1038/nrc3599 ↗
12. 10.1038/s41467-021-22024-310.1038/s41467-021-22024-3 ↗
13. 10.1158/0008-5472.CAN-20-410710.1158/0008-5472.CAN-20-4107 ↗
14. 10.1186/s13059-017-1347-310.1186/s13059-017-1347-3 ↗
15. 10.1038/s41576-018-0006-110.1038/s41576-018-0006-1 ↗
16. 10.1016/j.biochi.2015.05.02010.1016/j.biochi.2015.05.020 ↗
17. 10.1016/j.gde.2017.10.00910.1016/j.gde.2017.10.009 ↗
18. 10.1093/nar/gkw76710.1093/nar/gkw767 ↗
19. 10.1093/nar/gkt99610.1093/nar/gkt996 ↗
20. 10.1038/s41591-018-0302-510.1038/s41591-018-0302-5 ↗
21. 10.1186/1756-6606-7-510.1186/1756-6606-7-5 ↗
22. 10.1038/nm.417210.1038/nm.4172 ↗
23. 10.1016/j.tig.2019.09.00410.1016/j.tig.2019.09.004 ↗
24. 10.1093/nar/gky95810.1093/nar/gky958 ↗
25. 10.1016/j.pharmthera.2017.07.00310.1016/j.pharmthera.2017.07.003 ↗
26. 10.1111/cbdd.1204510.1111/cbdd.12045 ↗
27. Streit A. K. · Biochemistry · 2011 · 76 · 890
28. 10.1016/j.ccell.2015.08.01310.1016/j.ccell.2015.08.013 ↗
29. 10.1074/jbc.M117.77568410.1074/jbc.M117.775684 ↗
30. 10.1038/s41392-020-00300-w10.1038/s41392-020-00300-w ↗
31. 10.1073/pnas.090018910610.1073/pnas.0900189106 ↗
32. 10.1038/nature2404110.1038/nature24041 ↗
33. 10.1038/s41593-019-0463-710.1038/s41593-019-0463-7 ↗
34. 10.1021/mp300153z10.1021/mp300153z ↗
35. 10.1016/j.ygyno.2020.01.01310.1016/j.ygyno.2020.01.013 ↗
36. Liu X. · Oncol. Lett. · 2019 · 18 · 1304
37. 10.3389/fonc.2021.74602910.3389/fonc.2021.746029 ↗
38. 10.1093/bioinformatics/btr06410.1093/bioinformatics/btr064 ↗
39. 10.1158/0008-5472.CAN-16-018610.1158/0008-5472.CAN-16-0186 ↗
40. 10.1016/j.drup.2008.03.00110.1016/j.drup.2008.03.001 ↗
41. 10.1002/ijc.2083110.1002/ijc.20831 ↗
42. 10.1016/j.celrep.2020.10765610.1016/j.celrep.2020.107656 ↗
43. 10.1038/s42003-018-0271-810.1038/s42003-018-0271-8 ↗
44. 10.1177/096368972096107010.1177/0963689720961070 ↗
45. 10.3892/or.2017.597010.3892/or.2017.5970 ↗
46. 10.1038/sj.bjc.660119310.1038/sj.bjc.6601193 ↗
47. 10.1515/hsz-2017-012110.1515/hsz-2017-0121 ↗
48. 10.1158/1078-0432.CCR-21-071410.1158/1078-0432.CCR-21-0714 ↗
49. Tomida A. · Anticancer Drug Des. · 1999 · 14 · 169
50. 10.3390/cancers1011045810.3390/cancers10110458 ↗
51. 10.1038/s41571-020-0341-y10.1038/s41571-020-0341-y ↗
52. 10.1084/jem.190.2.25310.1084/jem.190.2.253 ↗
53. 10.1080/03602532.2019.163288610.1080/03602532.2019.1632886 ↗
54. 10.1007/s00280-006-0233-610.1007/s00280-006-0233-6 ↗
55. 10.1124/mol.119.11797810.1124/mol.119.117978 ↗
56. 10.3389/fimmu.2020.0090110.3389/fimmu.2020.00901 ↗
57. 10.1200/JCO.2010.34.361610.1200/JCO.2010.34.3616 ↗
58. Zeng‐Rong N. · Cancer Res. · 1995 · 55 · 4760
59. 10.1016/j.bbamcr.2020.11876110.1016/j.bbamcr.2020.118761 ↗
60. 10.1038/s41419-022-04668-110.1038/s41419-022-04668-1 ↗
61. 10.1038/s41588-020-00774-y10.1038/s41588-020-00774-y ↗
62. 10.1186/s13059-021-02269-310.1186/s13059-021-02269-3 ↗
63. 10.1038/nmeth.454010.1038/nmeth.4540 ↗
64. 10.1038/s41392-020-00420-310.1038/s41392-020-00420-3 ↗
65. 10.1371/journal.pcbi.100770110.1371/journal.pcbi.1007701 ↗
66. 10.1124/pr.118.01625310.1124/pr.118.016253 ↗
67. 10.1021/acs.analchem.2c0122610.1021/acs.analchem.2c01226 ↗
68. 10.1016/j.cell.2016.06.01710.1016/j.cell.2016.06.017 ↗
69. 10.1093/nar/gks111110.1093/nar/gks1111 ↗
70. Bailey T. L. · Proc. Int. Conf. Intell. Syst. Mol. Biol. · 1994 · 2 · 28
71. 10.1093/nar/gku40610.1093/nar/gku406 ↗
72. 10.1093/bioinformatics/btp61610.1093/bioinformatics/btp616 ↗
73. 10.7554/eLife.0500510.7554/eLife.05005 ↗
74. 10.1186/s13059-016-0924-110.1186/s13059-016-0924-1 ↗
75. 10.1038/s41467-019-09234-610.1038/s41467-019-09234-6 ↗
76. 10.1089/omi.2011.011810.1089/omi.2011.0118 ↗